SU5, a new Auraptene analog with improved metabolic stability, ameliorates nonalcoholic fatty liver disease in methionine‐ and choline‐deficient diet‐fed db/db mice.

Autor: Wen, Fen1,2 (AUTHOR), Bian, DeZhi2 (AUTHOR), Wu, XuDong2 (AUTHOR), Liu, RuoBing2 (AUTHOR), Wang, ChaoNan2 (AUTHOR), Gan, JianHe1 (AUTHOR) jianhegan123@163.com
Zdroj: Chemical Biology & Drug Design. Mar2022, Vol. 99 Issue 3, p504-511. 8p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje